Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt de Vlam

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Nature Reviews. Rheumatology|November 27, 2025
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiativeFabian Proft, Andre L Ribeiro, Shikha Singla, et al.
The Journal of Rheumatology|November 1, 2022
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment RecommendationsCristiano B Campanholo, Ajesh B Maharaj, Nadia Corp, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
Annals of the Rheumatic Diseases|June 2, 2025
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 studyPeter C Taylor, Philip J Mease, Kurt de Vlam, et al.
Arthritis Care & Research|December 21, 2016
Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European StudyCarole Desthieux, Benjamin Granger, Andra Rodica Balanescu, et al.
Joint Bone Spine|December 19, 2015
Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) studySandra Tälli, Adrien Etcheto, Bruno Fautrel, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Annals of the Rheumatic Diseases|July 17, 2012
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)Philip S Helliwell, Oliver FitzGerald, Jaap Fransen, et al.
The Lancet. Rheumatology|February 4, 2024
Nociceptive, neuropathic, or nociplastic low back pain? The low back pain phenotyping (BACPAP) consortium's international and multidisciplinary consensus recommendationsJo Nijs, Eva Kosek, Alessandro Chiarotto, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Nature Reviews. Rheumatology|November 27, 2025
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiativeFabian Proft, Andre L Ribeiro, Shikha Singla, et al.
The Journal of Rheumatology|November 1, 2022
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment RecommendationsCristiano B Campanholo, Ajesh B Maharaj, Nadia Corp, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
Annals of the Rheumatic Diseases|June 2, 2025
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 studyPeter C Taylor, Philip J Mease, Kurt de Vlam, et al.
Arthritis Care & Research|December 21, 2016
Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European StudyCarole Desthieux, Benjamin Granger, Andra Rodica Balanescu, et al.
Joint Bone Spine|December 19, 2015
Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) studySandra Tälli, Adrien Etcheto, Bruno Fautrel, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Annals of the Rheumatic Diseases|July 17, 2012
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)Philip S Helliwell, Oliver FitzGerald, Jaap Fransen, et al.
The Lancet. Rheumatology|February 4, 2024
Nociceptive, neuropathic, or nociplastic low back pain? The low back pain phenotyping (BACPAP) consortium's international and multidisciplinary consensus recommendationsJo Nijs, Eva Kosek, Alessandro Chiarotto, et al.
Pageof 14